News

Coverage is one step in the right direction, but there’s another part that is crucial.

New remote patient technology applications could be the new norm for healthcare.

How technology can improve patient and provider experiences.

How pen and paper can create risks for patient, providers, and visitors.

A new study has revealing findings about how millennials maintain their health and wellness.

A look at how consumerization is changing healthcare forever.

Increased transparency and consumer-friendliness are common goals in improving billing, but more work is needed.

How nonprofit hospitals and health systems are getting involved with housing.

Telehealth being used to fill patient care gaps.

Two organizations partner to help fund community-based organizations.

Millennials and Baby Boomers aren't so different after all. 

FDA approved the third oncology drug in the US that targets a key genetic driver of cancer, rather than a specific tumor.

Blockbuster drug could be key to Humira’s successor.

The mentors and lessons that have impacted your career.

The pharmacy spend increases health systems can expect.

Ambulatory surgery centers can aid managed care in closing gaps in services, smooth adoption, and coordinate training.

The changes health executives should make to help ease the burnout problem.

Regional health plans can quickly reduce their costs by 4% to 5% while increasing member satisfaction.

The states that ranked the lowest in seven different health factors.

How oncology practices can help reduce spending on cancer drugs-without compromising on patient care.

With a link between chronic health conditions and high spending, how can costs be lowered for patients, providers, and payers?

Why millennials are demanding more wellbeing support.

Report shows that healthcare is still at a high risk for data breaches.

The M&A trend isn’t showing any signs of slowing.

While FDA’s drug approval time is generally improving, the agency needs to speed up generic drug application reviews, according to a new report.

How to drive greater member activation and participation in their own care.

Individuals without their own prescriptions may be at risk for overdose if they have access to family members’ drugs, according to a new study

While FDA recently said Novartis and AveXis did not reveal data on their $2.1 million gene thaerpy for pediatric spinal muscular atrophy until after it was approved, Novartis is defending its actions.